NEW YORK, Oct. 5, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers

This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Global Cardiovascular Drug Market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:

• Sales forecast for major product segments: ethical, OTC, generics.

• Sales forecast for major drug categories.

• Sales forecasts by geographical region: North America, Europe, Japan, Latin America.

In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.

The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report's major objectives include:

• To establish a comprehensive, factual, annually updated and cost-effective informat